Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

STX

Shield Therapeutics (STX)

Shield Therapeutics Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:STX
DateTimeSourceHeadlineSymbolCompany
03/04/20195:47AMAlliance NewsAlliance NewsShield Therapeutics Jumps A Fifth Amid Feraccru Clinical Trial SuccessLSE:STXShield Therapeutics Plc
03/04/20192:01AMUK RegulatoryShield Therapeutics PLC Positive results for Feraccru® in AEGIS-H2H studyLSE:STXShield Therapeutics Plc
01/29/20196:21AMAlliance NewsAlliance NewsShield Therapeutics Gets Positive Results From Feraccru StudyLSE:STXShield Therapeutics Plc
01/29/20192:00AMUK RegulatoryShield Therapeutics PLC Positive results of AEGIS-CKD studyLSE:STXShield Therapeutics Plc
01/24/20199:16AMAlliance NewsAlliance NewsShield Therapeutics Expects 2018 Revenue Growth On Licence PaymentsLSE:STXShield Therapeutics Plc
01/24/20192:00AMUK RegulatoryShield Therapeutics PLC Business and trading updateLSE:STXShield Therapeutics Plc
01/23/20195:19AMRNS Non-RegulatoryShield Therapeutics PLC Investor presentationsLSE:STXShield Therapeutics Plc
01/22/20198:35AMAlliance NewsAlliance NewsShield Therapeutics Appoints Director James Karis As ChairLSE:STXShield Therapeutics Plc
01/22/20192:00AMUK RegulatoryShield Therapeutics PLC Appointment of ChairmanLSE:STXShield Therapeutics Plc
12/13/20189:24AMAlliance NewsAlliance NewsShield Therapeutics Expects FDA Ferracru Review By July 27LSE:STXShield Therapeutics Plc
12/13/20182:00AMUK RegulatoryShield Therapeutics PLC US New Drug Application PDUFA date for FeraccruLSE:STXShield Therapeutics Plc
12/05/20186:57AMAlliance NewsAlliance NewsShield Therapeutics Partner Norgine Launches Feraccru In UKLSE:STXShield Therapeutics Plc
12/05/20185:04AMRNS Non-RegulatoryShield Therapeutics PLC UK launch of Feraccru® by NorgineLSE:STXShield Therapeutics Plc
12/03/20187:02AMAlliance NewsAlliance NewsUS FDA Accepts Shield Therapeutics' Ferracru New Drug ApplicationLSE:STXShield Therapeutics Plc
12/03/20182:01AMUK RegulatoryShield Therapeutics PLC New Drug Application for Feraccru®LSE:STXShield Therapeutics Plc
11/09/201810:46AMUK RegulatoryShield Therapeutics PLC Holding(s) in CompanyLSE:STXShield Therapeutics Plc
11/08/20181:21PMUK RegulatoryShield Therapeutics PLC Holding(s) in CompanyLSE:STXShield Therapeutics Plc
10/01/20188:54AMUK RegulatoryShield Therapeutics PLC Notification Of Major HoldingsLSE:STXShield Therapeutics Plc
10/01/20187:44AMAlliance NewsAlliance NewsShield Therapeutics Submits New Drug Application To FDA For FeraccruLSE:STXShield Therapeutics Plc
10/01/20182:00AMUK RegulatoryShield Therapeutics PLC Submission of an NDA for Feraccru® with the FDALSE:STXShield Therapeutics Plc
09/24/20189:30AMAlliance NewsAlliance NewsDIRECTOR DEALINGS: Shield Therapeutics Boss Sterritt Buys More StockLSE:STXShield Therapeutics Plc
09/24/20188:06AMUK RegulatoryShield Therapeutics PLC Director/PDMR ShareholdingLSE:STXShield Therapeutics Plc
09/24/20188:02AMUK RegulatoryShield Therapeutics PLC Holding(s) in CompanyLSE:STXShield Therapeutics Plc
09/19/20187:09AMAlliance NewsAlliance NewsShield Therapeutics Interim Loss Narrows, Ferracru Wins ContractLSE:STXShield Therapeutics Plc
09/19/20182:14AMUK RegulatoryShield Therapeutics PLC Licence for the commercialisation of FeraccruLSE:STXShield Therapeutics Plc
09/19/20182:12AMUK RegulatoryShield Therapeutics PLC Interim ResultsLSE:STXShield Therapeutics Plc
09/13/20186:51AMAlliance NewsAlliance NewsShield Therapeutics Completes Recruitment For Feraccru TrialLSE:STXShield Therapeutics Plc
09/13/20182:00AMUK RegulatoryShield Therapeutics PLC AEGIS-H2H Completion of RecruitmentLSE:STXShield Therapeutics Plc
07/26/20188:05AMAlliance NewsAlliance NewsShield Therapeutics Appoints Hans-Peter Hasler To BoardLSE:STXShield Therapeutics Plc
07/26/20182:02AMUK RegulatoryShield Therapeutics PLC Appointment of Non-Executive DirectorLSE:STXShield Therapeutics Plc
 Showing the most relevant articles for your search:LSE:STX